CLOs on the Move

Sientra

www.sientra.com

 
Headquartered in Santa Barbara, California, Sientra offers leading transformative treatments and technologies focused on progressing the art of plastic surgery and making a difference in patients` lives. With unrivaled safety, state-of-the-art science and exceptional service; paired with unparalleled partnerships with plastic surgeons, the Sientra portfolio of proprietary innovations radically advances how plastic surgeons think, work and care for their patients. The company`s core breast products segment includes its state-of-the-art Sientra breast implants and its ground-breaking dual-port breast tissue expander, AlloX2® . In addition, the Sientra portfolio also includes BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*) ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.sientra.com
  • 420 South Fairview Avenue Suite 200
    Santa Barbara, CA USA 93117
  • Phone: 805.562.3500

Executives

Name Title Contact Details

Similar Companies

J and B Medical Supply

J and B Medical Supply, Inc. is a Wixom, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Canadian Hospital Specialties

Canadian Hospital Specialties Ltd is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

VQ OrthoCare

VQ OrthoCare is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Elucid

Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe

MEDICAL EQUIPMENT RESOURCES

MEDICAL EQUIPMENT RESOURCES is a Woodlyn, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.